Galera Therapeutics (GRTX) to Release Earnings on Monday

Galera Therapeutics (NASDAQ:GRTX) is expected to post its results before the market opens on Monday, May 11th. Analysts expect Galera Therapeutics to post earnings of ($0.8313) per share for the quarter.

Galera Therapeutics Trading Up 11.2%

Shares of NASDAQ:GRTX traded up $0.01 on Monday, hitting $0.10. The company had a trading volume of 136,189 shares, compared to its average volume of 245,609. The stock has a 50 day moving average price of $0.06 and a 200 day moving average price of $0.03. The stock has a market cap of $7.55 million, a price-to-earnings ratio of -0.29 and a beta of 2.63. Galera Therapeutics has a 1-year low of $0.02 and a 1-year high of $0.15.

About Galera Therapeutics

Galera Therapeutics, Inc is a clinical-stage biotechnology company headquartered in Malvern, Pennsylvania. The company focuses on developing precision medicines designed to address oxidative stress and inflammation in pulmonary and rare diseases. Galera’s proprietary platform centers on small-molecule prodrugs of glutathione and related thiol compounds intended to enhance intracellular antioxidant defenses.

Galera’s lead product candidate is an inhaled glutathione prodrug currently in early-stage clinical trials for acute lung injury and acute respiratory distress syndrome.